AstraZeneca Makes $275 Million in Sales from Covid-19 Vaccine

AstraZeneca's Covid-19 jab was developed with the University of Oxford and has been key in Britain's rapid vaccination drive. The company is selling it at cost price.

from Top Business News- News18.com